Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

ClinicalPain ManagementAnesthesiaTrial Update

Study Compares Systemic Lidocaine to Adductor Canal Block in Knee Surgery

This study evaluates postoperative outcomes in total knee arthroplasty patients receiving systemic lidocaine versus an adductor canal block.

Published: July 29, 2026
Updated: July 29, 2026
Author: Humanexa Intelligence
Therapeutic area: Pain Management / Anesthesia
Asset: Study
Trial SummaryCLN

Phase III

Pain Management / Anesthesia

Status

Active

Signal Score

8.2

Signal assessment

Signal strength

high

Confidence level

moderate

Signalhigh
Confidencemoderate

Why it matters

This study could significantly impact clinical practices in pain management for orthopedic surgeries, particularly total knee arthroplasties. The findings may lead to changes in anesthetic protocols, influencing product development and competitive positioning in the pain management market.

Recommended action

Humanexa recommends Monitor.

Analysis

Monitor for study results and potential shifts in clinical practice guidelines based on findings.

Related companies & assets

Assets

  • Study →
  • pain management protocols →

Sources & Humanexa intelligence

Source links

  • Study Compares Systemic Lidocaine to Adductor Canal Block in Knee Surgery ↗

Related Humanexa pages

  • Study Compares Systemic Lidocaine to Adductor Canal Block in Knee Surgery →

Related signals

Trial SummaryCLN

Phase I

Oncology / CAR T-cell Therapy

Status

Active

Sponsor

TSLPR-CART

Signal Score

8.4

Clinicalhigh signal

Phase 1 Trial of TSLPR-CART in Refractory B-ALL Shows Promise for Targeting TSLPR Overexpression

A clinical trial is underway to evaluate TSLPR-CART therapy in adults with recurrent or refractory B-ALL characterized by TSLPR overexpression.

August 6, 2026Read signal →
Trial SummaryCLN

Phase III

Oncology / Multiple Myeloma

Status

Active

Signal Score

8.4

Clinicalhigh signal

Selinexor shows promise in high-risk multiple myeloma with XVRd regimen

The study evaluates the efficacy and safety of the XVRd regimen in newly diagnosed multiple myeloma patients with high-risk factors.

August 5, 2026Read signal →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.

  1. Home
  2. /Clinical
  3. /Study Compares Systemic Lidocaine to Adductor Canal Block in Knee Surgery